Literature DB >> 19322555

[Highly active antiretroviral therapy of neuro-AIDS. Side effects on the nervous system and interactions].

I W Husstedt1, D Reichelt, E Neuen-Jakob, K Hahn, F Kästner, R von Einsiedel, B Vielhaber, G Arendt, S Evers.   

Abstract

Highly active antiretroviral therapy (HAART) has increased the mean survival time in the AIDS stage to sometimes more than 10 years. Five different groups of antiretroviral medications are known, of which integrase inhibitors and CCR5 antagonists represent the newest and most modern substances. The long AIDS survival time implies that side effects and interactions become relatively more important and must be differentiated from the symptoms of HIV itself. Side effects of HAART concern the central and peripheral nervous system and the muscles. The neurotoxicity of the components in HAART varies considerably and depends on the substance itself. Knowledge of side effects and interactions of HAART with antiepileptics, antidepressants, and analgetics are essential for the treatment of patients with neuro-AIDS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19322555     DOI: 10.1007/s00115-009-2684-6

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  46 in total

Review 1.  Human immunodeficiency virus-associated dementia: an evolving disease.

Authors:  Justin C McArthur; Norman Haughey; Suzanne Gartner; Kathy Conant; Carlos Pardo; Avi Nath; Ned Sacktor
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

2.  Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity.

Authors:  Jacqueline A Pettersen; Gareth Jones; Catherine Worthington; Hartmut B Krentz; Oliver T Keppler; Ahmet Hoke; M John Gill; Christopher Power
Journal:  Ann Neurol       Date:  2006-05       Impact factor: 10.422

3.  Depressive symptoms predict increased incidence of neuropsychiatric side effects in patients treated with efavirenz.

Authors:  Larry Boly; Virginia Cafaro; Toby Dyner
Journal:  J Acquir Immune Defic Syndr       Date:  2006-08-01       Impact factor: 3.731

Review 4.  Seizures in HIV-seropositive individuals: epidemiology and treatment.

Authors:  Frank Romanelli; Melody Ryan
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 5.  Complications associated with NRTI therapy: update on clinical features and possible pathogenic mechanisms.

Authors:  David Nolan; Simon Mallal
Journal:  Antivir Ther       Date:  2004-12

6.  Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase.

Authors:  A A Johnson; A S Ray; J Hanes; Z Suo; J M Colacino; K S Anderson; K A Johnson
Journal:  J Biol Chem       Date:  2001-08-28       Impact factor: 5.157

Review 7.  [Peripheral nerve diseases and myopathies associated with HIV infection].

Authors: 
Journal:  Nervenarzt       Date:  2000-06       Impact factor: 1.214

8.  Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients.

Authors:  Hélène C F Côté; Zabrina L Brumme; Kevin J P Craib; Christopher S Alexander; Brian Wynhoven; Lillian Ting; Hubert Wong; Marianne Harris; P Richard Harrigan; Michael V O'Shaughnessy; Julio S G Montaner
Journal:  N Engl J Med       Date:  2002-03-14       Impact factor: 91.245

9.  Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS.

Authors:  B S Peters; J Winer; D N Landon; A Stotter; A J Pinching
Journal:  Q J Med       Date:  1993-01

10.  Depression is common among AIDS patients. Psych consult often is necessary.

Authors: 
Journal:  AIDS Alert       Date:  2002-12
View more
  1 in total

Review 1.  Animal models for depression associated with HIV-1 infection.

Authors:  Isabella Cristina Gomes Barreto; Patricia Viegas; Edward B Ziff; Elisabete Castelon Konkiewitz
Journal:  J Neuroimmune Pharmacol       Date:  2013-12-12       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.